4-(3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-pentanoic acid amides wherein the nitrogen of the amide group is substituted by a sulfonylaminocarbonyl-(C
1-4
)-alkyl group; and the use of such compounds as pharmaceuticals.
4-(3-羟基-10,13-二甲基-
十六烷基环戊-α-苯并
芘-17-基)-
戊酸酰胺,其中酰胺基的氮原子被磺酰
氨基羰基-(C1-4)-烷基取代;以及将这些化合物用作药物的用途。